Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Operating activities
Net loss	$ (20,546)	$ (38,191)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	20,372	23,585
Paid in kind and non-cash interest	16,390	14,874
Stock-based compensation	2,550	3,656
Provision for losses on accounts receivable	2,167	1,736
Deferred income taxes	629	728
Change in fair value of contingent consideration		21
Change in fair value of Private Warrants	(559)	(826)
Changes in operating assets and liabilities:
Accounts receivable	(4,622)	(3,828)
Prepaid expenses and other assets	(8,277)	(5,464)
Accounts payable and accrued expenses	(691)	6,791
Deferred revenue	(1,847)	(1,033)
Net cash provided by operating activities	5,566	2,049
Investing activities
Purchases of property and equipment	(8,534)	(10,498)
Net cash used in investing activities	(8,534)	(10,498)
Financing activities
Payments for capital lease obligations	(1,874)	(1,592)
Payments on long-term debt	(2,250)	(2,250)
Net cash used in by financing activities	(4,124)	(3,842)
Effect of foreign exchange rates	(102)	(1,304)
Net decrease in cash	(7,194)	(13,595)
Cash and cash equivalents at beginning of period	32,629	46,468
Cash and cash equivalents at end of period	25,435	32,873
Supplemental disclosure:
Cash paid for interest	33,216	24,871
Net income taxes paid	788	486
Significant noncash investing and financing activities
Purchases of property and equipment in accounts payable and accrued expenses on the condensed consolidated balance sheets	$ 133	$ 115